PTC Therapeutics Inc (PTCT)
43.05
+0.16
(+0.37%)
USD |
NASDAQ |
Nov 22, 10:10
PTC Therapeutics Debt to Equity Ratio: -0.2704 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.2704 |
| June 30, 2024 | -0.2906 |
| March 31, 2024 | -0.3183 |
| December 31, 2023 | -2.563 |
| September 30, 2023 | -0.8545 |
| June 30, 2023 | -0.9886 |
| March 31, 2023 | -1.250 |
| December 31, 2022 | -3.831 |
| September 30, 2022 | -1.246 |
| June 30, 2022 | -2.373 |
| March 31, 2022 | -4.768 |
| December 31, 2021 | 810.44 |
| September 30, 2021 | 4.107 |
| June 30, 2021 | 2.19 |
| March 31, 2021 | 1.470 |
| December 31, 2020 | 0.6414 |
| September 30, 2020 | 0.593 |
| June 30, 2020 | 0.5509 |
| March 31, 2020 | 0.595 |
| December 31, 2019 | 0.5281 |
| September 30, 2019 | 0.4719 |
| June 30, 2019 | 0.3186 |
| March 31, 2019 | 0.3024 |
| December 31, 2018 | 0.4363 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.3909 |
| June 30, 2018 | 0.5567 |
| March 31, 2018 | 0.9772 |
| December 31, 2017 | 0.9267 |
| September 30, 2017 | 0.9809 |
| June 30, 2017 | 0.8322 |
| March 31, 2017 | 0.9908 |
| December 31, 2016 | 0.8213 |
| September 30, 2016 | 0.6888 |
| June 30, 2016 | 0.5732 |
| March 31, 2016 | 0.4764 |
| December 31, 2015 | 0.4064 |
| September 30, 2015 | 0.3463 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.0004 |
| September 30, 2013 | 0.0006 |
| June 30, 2013 | 0.018 |
| March 31, 2013 | 0.1125 |
| December 31, 2012 | -0.2544 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.768
Minimum
Mar 2022
810.44
Maximum
Dec 2021
40.12
Average
-0.2805
Median
Debt to Equity Ratio Benchmarks
| ClearPoint Neuro Inc | 0.00 |
| Pfizer Inc | 0.7219 |
| Vertex Pharmaceuticals Inc | 0.00 |
| BridgeBio Pharma Inc | -1.398 |
| Cassava Sciences Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.842B |
| Total Liabilities (Quarterly) | 2.897B |
| Shareholders Equity (Quarterly) | -1.054B |
| Current Ratio | 2.098 |
| Net Debt Paydown Yield | 2.01% |